Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn StudyA Jager, V W van Hinsbergh, P J Kostense, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2014
Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaqueNynke A Jager, Johanna Westra, Reza Golestani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patientsP M L H Vencken, M Kriege, D Hoogwerf, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2012
Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaqueNynke A Jager, Johanna Westra, Gooitzen M van Dam, et al.Critical Reviews in Oncology/Hematology|July 17, 2012
Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guidelineF Y F L De Vos, H W M van Laarhoven, J S E Laven, et al.Breast Cancer Research and Treatment|May 24, 2023
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancerM K Bos, S W Lam, G Motta, et al.Molecular Imaging and Biology|September 18, 2015
Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage SubsetsNynke A Jager, Bastiaan M Wallis de Vries, Jan-Luuk Hillebrands, et al.British Journal of Cancer|June 12, 2014
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapyM Kriege, A Hollestelle, A Jager, et al.ESMO Open|February 8, 2023
The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancerS M Buijs, E Oomen-de Hoop, C L Braal, et al.Acta Oncologica (Stockholm, Sweden)|March 4, 2015
The accuracy of target delineation in laryngeal and hypopharyngeal cancerJoana Caldas-Magalhaes, Nina Kooij, Hans Ligtenberg, et al.Pageof 7